Fresenius

The Nation's Leading Advanced Manufacturing Event Reveals a Virtual Continuation of the Onsite Experience held in Anaheim, California

Retrieved on: 
Tuesday, August 24, 2021
Packaging, Electronic Design Automation, Engineering, Technology, Manufacturing, Other Manufacturing, Anaheim Convention Center, Original design manufacturer, NuVasive, Medtronic, RJG, D, Glenaire, Network, Niagara Bottling, NEW, Honeywell, Fresenius, Plastic, Northrop Grumman, GKN, Environment, Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., ATX, Zebra Technologies, GE Healthcare, Solution, Exhibition, Conference, VP, Herbalife Nutrition, Health, USENIX Annual Technical Conference, MD, Video game, Online shopping, Informa Markets –, Informa Markets, INFORMA MARKETS –, INFORMA MARKETS

Serving as an all-new virtual platform, West+ is strategically designed to facilitate further industry connection and deal-making that was initiated onsite earlier this month.

Key Points: 
  • Serving as an all-new virtual platform, West+ is strategically designed to facilitate further industry connection and deal-making that was initiated onsite earlier this month.
  • "This year's event was particularly special for a number of reasons," said Melissa Magestro, VP and Group Portfolio Leader, Informa Markets Engineering West.
  • The three pillars of the virtual event include:
    Free Webinars Rewind the clock and sit in on the educational sessions you missed onsite.
  • The event has served the advanced design and manufacturing community in Anaheim for more than 30 years.

Disc Medicine Appoints Will Savage, MD, PhD as Chief Medical Officer and Jonathan Yu as Chief Business Officer and Expands Scientific Leadership with Key Hires to Advance Clinical-Stage Pipeline

Retrieved on: 
Monday, August 23, 2021
University of Nebraska Medical Center, BA, PKR, Regulatory affairs, MS, IDH1, University, Program, Agios Pharmaceuticals, Interferon beta-1a, RAC, Trial of the century, MAA, Leadership, Drug discovery, AML, Medicine, Doctor of Philosophy, JD, Biogen, University of Dayton School of Law, Fudan University, NDA, Anemia, DMPK, Inflammation, Fresenius, Multimedia, Baxter, Hematologic disease, Porphyria, Sodium- and chloride-dependent glycine transporter 1, Patient, NSCLC, Law, Bristol Myers Squibb, BLA, Degenerative disease, Patent, Nebraska Medicine, MD, Pharmaceutical industry, Management

"I want to congratulate Will and Jonathan on their respective promotions and welcome both Hua and Sarah to the company.

Key Points: 
  • "I want to congratulate Will and Jonathan on their respective promotions and welcome both Hua and Sarah to the company.
  • I'm thrilled to work with this team as we advance our clinical-stage pipeline deep into development."
  • Disc Medicine is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders.
  • We are building a unique portfolio of innovative, first-in-class therapeutic candidates based on fundamental pathways of red blood cell biology.

DGAP-News: Fresenius Medical Care AG & Co. KGaA reports results in line with expectations for the second quarter and confirms 2021 outlook

Retrieved on: 
Friday, July 30, 2021
Bad Homburg vor der Höhe, Fresenius, Germany, Health care

Based on the results for the second quarter and first half, Fresenius Medical Care confirms its outlook for FY 2021 as outlined in February.

Key Points: 
  • Based on the results for the second quarter and first half, Fresenius Medical Care confirms its outlook for FY 2021 as outlined in February.
  • Sustainability is an integral part of Fresenius Medical Care's mission and vision and is reflected in the corporate strategy.
  • These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

Retrieved on: 
Wednesday, July 28, 2021
Bad Homburg vor der Höhe, Fresenius, Societates Europaeae, Germany, Industry economics), Companies

BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the Company or Option Care Health)(Nasdaq: OPCH), the nations largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer.

Key Points: 
  • BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the Company or Option Care Health)(Nasdaq: OPCH), the nations largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer.
  • Prior to joining Option Care Health, Dr. Kumbhat served as Senior Vice President and Regional Medical Officer for Fresenius Kabi.
  • As a physician, she brings a wealth of knowledge to the Option Care Health team, and Im confident she will make a positive impact in continuing efforts to elevate patient care, John Rademacher, Chief Executive Officer, commented.
  • Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates.

Fresenius Medical Care North America Announces New President for Renal Therapies Group

Retrieved on: 
Thursday, July 22, 2021
Bad Homburg vor der Höhe, Private providers of NHS services, Fresenius, Societates Europaeae, Germany, Health care, Diaverum

WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.

Key Points: 
  • WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.
  • Turk succeeds Mark Costanzo, who recently retired as President of FMCNA's Renal Therapies Group.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent.

UPS Healthcare Announces Agreement With Fresenius Medical Care, Expanding Service In The UK

Retrieved on: 
Thursday, July 22, 2021
Bad Homburg vor der Höhe, Private providers of NHS services, Fresenius, Societates Europaeae, Germany, Health care

Through this agreement, Polar Speed will assume operation of Fresenius Medical Care's facility in Huthwaite, Nottinghamshire, UK, adding to Polar Speed's GDP-compliant depot network.

Key Points: 
  • Through this agreement, Polar Speed will assume operation of Fresenius Medical Care's facility in Huthwaite, Nottinghamshire, UK, adding to Polar Speed's GDP-compliant depot network.
  • Wes Wheeler, President of UPS Healthcare, said, "UPS Healthcare is delighted to work with Fresenius Medical Care as a supply chain partner in the UK.
  • "One of the ongoing strategic priorities for Fresenius Medical Care is to constantly review and improve our operations," said Tim Wheeldon, Managing Director and Head of Fresenius Medical Care UK and Ireland.
  • Fresenius Medical Care UK has been caring for NHS kidney patients in the UK for over 20 years.

Clinical Nutrition Market - Global Outlook and Forecast 2021-2026 with Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science Dominating - ResearchAndMarkets.com

Retrieved on: 
Monday, July 19, 2021
General Health, Pharmaceutical, Health, Food and drink, Companies, Industry economics), Medical food, Nutricia, Danone, European Society for Clinical Nutrition and Metabolism, Fresenius, Nestlé, Clinical nutrition, Wellness

The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography.

Key Points: 
  • The global clinical nutrition market research report includes a detailed segmentation by route of administration, age group, product type, application, distributional channels, end-users, geography.
  • Focusing on health and wellness, aging well, and disease prevention by consumers, healthcare providers are demanding preventive clinical nutrition products and are experiencing rapid growth.
  • Global brands such as Abbott, Nestle, Nutricia, and Fresenius Kabi offer parenteral, enteral, and oral nutrition products for infants.
  • Abbott Laboratories, Baxter International, B. Braun, Danone, and Nestle Health Science are the major players.

Ambulnz Launches Service in Illinois

Retrieved on: 
Wednesday, July 14, 2021
Medicine, Clinical medicine, Health care, Membrane technology, Bad Homburg vor der Höhe, Detoxification, Dialysis, Renal dialysis, Fresenius, American Kidney Fund, Home hemodialysis

With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.

Key Points: 
  • With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.
  • Ambulnz will assist people getting to and from scheduled dialysis appointments.
  • Dialysis patients in Illinois using Ambulnz services can now get dedicated and reliable transportation to and from their kidney dialysis appointments.
  • Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.

Xenios AG receives approval in China for ECMO devices

Retrieved on: 
Tuesday, July 13, 2021
General Health, Health, Other Health, Bad Homburg vor der Höhe, Health care, Intensive care medicine, Medicine, Extracorporeal membrane oxygenation, Medical equipment, Membrane technology, Fresenius, Germany, Xenios AG, Fresenius Medical Care, XENIOS AG, FRESENIUS MEDICAL CARE

In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.

Key Points: 
  • In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.
  • As a result, a complete Xenios system is now permitted for ECMO therapy in China.
  • This Xenios ECMO complete system is certified in China for nine days application period.
  • The expedited approval was a joint effort by Xenios and Fresenius Medical Care China Team.

Fresenius Kabi Introduces New Simplist® Fentanyl Citrate Injection, USP 50 mcg per 1 mL in Ready-to-Administer Prefilled Syringe

Retrieved on: 
Tuesday, July 6, 2021
Medical Supplies, Health, Medical devices, Fitness & Nutrition, General Health, Pharmaceutical, Biotechnology, Drugs, Psychoactive drugs, Pharmacology, Euphoriants, Medical equipment, Fentanyl, Syringe, Fresenius, Heroin, Injection, Simplist® Fentanyl MicroVault® Prefilled Syringe, Fresenius Kabi, SIMPLIST® FENTANYL MICROVAULT® PREFILLED SYRINGE, FRESENIUS KABI

Fresenius Kabi announced today the U.S. introduction of Fentanyl Citrate Injection, USP 50 mcg per 1 mL in its proprietary Simplist ready-to-administer prefilled syringe, the only 1 mL presentation available in the U.S. today.

Key Points: 
  • Fresenius Kabi announced today the U.S. introduction of Fentanyl Citrate Injection, USP 50 mcg per 1 mL in its proprietary Simplist ready-to-administer prefilled syringe, the only 1 mL presentation available in the U.S. today.
  • View the full release here: https://www.businesswire.com/news/home/20210706005025/en/
    Fresenius Kabi Simplist Fentanyl ready-to-administer prefilled syringes come in the proprietary MicroVault packaging system.
  • Fresenius Kabi is a leader in injectable medicines with a growing U.S. portfolio of prefilled syringes.
  • The Simplist Fentanyl prefilled syringe is manufacturer prepared in the United States, with a 24-month shelf life, and is a single-unit dose, supporting best practices for medication administration.